header image

N.J. Strikes Deal for Discounted Doses of Heroin antidote

New Jersey has struck a deal with a California-based pharmaceutical company to receive rebates on Naloxone, the highly successful drug that reverses the effects of a heroin overdose almost instantly.

The deal comes months after the price of Naloxone, commonly known as Narcan, doubled last year, concerning officials who worried spiraling costs would put the effective treatment out of the reach of law enforcement and the public. Amphastar, the company that manufactures the nasally-administered form of the drug, agreed to cap prices of the drug and issue an approximately 20 percent rebate on doses of the drug issued to New Jersey law enforcement or other public entities, bringing the price down to about $23 per syringe.

Read full Star Ledger article here:

About the author